131I-mIBG in combination with topotecan in neuroblastoma patients with a poor response to induction chemotherapy (VERITAS)

Gianpaolo Di Santo

Presentation information

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Therapy1

PSMA, PRRT, MIBG

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-20-6] 131I-mIBG in combination with topotecan in neuroblastoma patients with a poor response to induction chemotherapy (VERITAS)

Gianpaolo Di Santo、martin Jeller、gabriele Kropshofer、Roman Crazzolara、Benjamin Hetzer、Lukas Wirth、Anna Sviridenko、Irene Virgolini (Medical University of Innsbruck)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

« Previous in this session
Next in this session »

▲

Presentation information

Therapy1

PSMA, PRRT, MIBG

[WP-20-6] 131I-mIBG in combination with topotecan in neuroblastoma patients with a poor response to induction chemotherapy (VERITAS)

Password